Lodelcizumab (Anti-PCSK9)
Lodelcizumab is a human monoclonal antibody targated against proprotein convertase subtilisin/kexin type 9 (PCSK9) with the potential to be used in research on hypercholesterolemia. MW: 145.66 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2924 |
Sku # | A2924-1mg*5 |
Pricing | 1mg*5, $1690.00 |